longbridgelongbridge
  • Platform Features
    Features
    Investment ProductsPrivate Wealth ManagementTrading ToolsMarket Data ServicesAnalysis ToolsNews ServicesFor Developers
    Account Types
    For IndividualsFor Institutions
  • Café
longbridge
© 2026 Longbridge|Terms of ServicePrivacy Policy

AquaBounty Tech

AQB

1.17010.38% ( +0.110 )
Trading: Sep 11, 12:12:10 (EDT)
Start trading
OverviewOverviewNewsNewsPostsPostsFinancialsFinancialsForecastForecastValuationValuationShareholdersShareholdersProfileProfile
LongbridgeAI

Current ValuationThe current P/E ratio is -0.30, within the reasonable range, cheaper than 48.58% of the time in the past 5 years, and the industry ranks 108/600, the industry Median -2.56.

-0.297xP/E
$1.06Stock price
$-3.57Earnings per share
-0.297xP/E
Stock price$1.06Earnings per share$-3.57

Historical Valuation

P/E ratioTypical rangeMedian
P/E ratio
-0.31x
Typical range
-3.44x–-0.05x

Peer P/E ratio Comparison

It displays how the company's P/E ratio compares to top companies within its industry.
018365472

The industry median valuation is currently at or below 0 and may not serve as a meaningful benchmark.

Industry P/E ratio Comparison

This shows the distribution of companies by P/E ratio range and their projected earnings per share growth for the next fiscal year.
0x30x60x90x120x150x
P/E ratio
Name/Symbol
GILDUSGilead Sciences
-55.42x148.77%$179.56B
CSLLYUSCSL Limited
-22.40x--$57.78B
MRNAUSModerna
-17.31x15.47%$54.54B
NTRAUSNatera
-244.41x10.38%$47.01B
RVMDUSRevolution Medicines
-24.65x64.29%$43.59B
ROIVUSRoivant Sciences
-111.07x148.13%$29.57B
INSMUSInsmed
-31.76x74.55%$27.80B
BNTXUSBioNTech SE
-12.37x19.96%$24.22B
BBIOUSBridgebio Pharma
-20.49x28.75%$14.17B
SMMTUSSummit Therapeutics
-15.84x18.42%$13.56B
MDGLUSMadrigal Pharma
-37.89x50.86%$12.32B
ARWRUSArrowHead Pharma
-36.54x36,308.30%$11.69B
CYTKUSCytokinetics
-11.45x6.37%$10.23B
ABVXUSAbivax SA
-26.04x32.59%$10.11B
KYMRUSKymera Therapeutics
-32.47x4.94%$9.73B
PRAXUSPraxis Precision Medicines
-27.87x3.05%$9.45B
IONSUSIonis Pharma
-16.36x52.66%$9.25B
PCVXUSVaxcyte
-8.24x48.80%$8.76B
TWSTUSTwist Bioscience
-61.08x24.70%$8.35B
IBRXUSImmunityBio
-8.24x152.63%$8.18B

Risk Warning

Timeframes using financial data from S&P Global. The feature provides key metrics such as price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S) ratios, and dividend yield. For reference only and does not constitute investment advice.